How long skin trials run before anyone measures

Section 01

The durations, condition by condition

Eczema and psoriasis run longest because both are dominated by injected medicines that need safety follow-up. Acne runs shortest despite affecting people for years, because the outcome — counting spots — can be measured quickly and a sponsor has no reason to keep paying once the number moves.[1][2]

Section 02

The gap between duration and treatment time

A recorded duration of 10 months does not mean participants used the treatment for 10 months. That span covers recruiting people, treating them, following them up and closing the study. For topical skin treatments the treatment window itself is commonly 12 to 16 weeks, and the main measurement is usually taken at the end of it.[2][4]

Twelve weeks is not an arbitrary choice. It is roughly how long skin takes to show a reliable change in acne counts, pigmentation or fine lines, and it is short enough to keep a study affordable. It is also the origin of the advice, repeated everywhere, to give a new product twelve weeks — that number came from trial design.[3][4]

Section 03

What a short window cannot see

• Whether the benefit lasts. A treatment that works for 12 weeks may plateau, or the condition may adapt around it.[4][2]
• What happens when you stop. Most skin conditions return, but trials rarely follow people through stopping.[4][3]
• Slow harms. Thinning, pigment change and tolerance build over months to years, past the end of most studies.[4]
• Whether people keep using it. Real-world adherence collapses over time, and a treatment nobody continues does not work in practice.[3][4]

Section 04

The seasonal problem nobody controls for

Skin conditions swing with the seasons. Eczema and psoriasis usually worsen in winter; acne and melasma often worsen with heat and sun. A 12-week study that runs from March to June will flatter a psoriasis treatment and punish a melasma one, and the registry does not record when in the year most studies ran.[2][4]

This is one reason results that look strong in a single trial soften when several are pooled. It is also a reason to judge your own results across a full year rather than a single season before concluding a treatment failed.[4][3]

Section 05

What to do with this

Match your patience to the trial window. Twelve weeks of consistent use before judging is the standard that the evidence itself was built on, and stopping at four weeks means you have tested nothing. Change one variable at a time so the twelve weeks tell you something.[3][4]

Then treat everything after that window as unmeasured. When a clinician says they do not know whether a treatment still helps after three years, that is not evasiveness, it is an accurate description of what has been studied. Ask instead about the plan for reviewing it.[4][5]